Okla. Stat. tit. 63, § 63-2-208: Schedule III

The controlled substances listed in this section are included in

Schedule III.

A. Unless listed in another schedule, any material, compound,

mixture, or preparation, which contains any quantity of the

following substances or any other substance having a potential for

abuse associated with a stimulant or depressant effect on the

central nervous system:

1. Any drug product containing gamma-hydroxybutyric acid,

including its salts, isomers, and salts of isomers, for which an

application has been approved under Section 505 of the Federal Food,

Drug, and Cosmetic Act;

2. Any material, compound, mixture, or preparation which

contains any quantity of the following hormonal substances or

steroids, including their salts, isomers, esters and salts of

isomers and esters, when the existence of these salts, isomers,

esters, and salts of isomers and esters is possible within the

specific chemical designation:

a. Boldenone,

b. Chlorotestosterone,

c. Clostebol,

d. Dehydrochlormethyltestosterone,

e. Dihydrotestosterone,

f. Drostanolone,

g. Ethylestrenol,

h. Fluoxymesterone,

i. Formebolone,

j. Mesterolone,

k. Methandienone,

l. Methandranone,

m. Methandriol,

n. Methandrostenolone,

o. Methenolone,

p. Methyltestosterone, except as provided in subsection E

of this section,

q. Mibolerone,

r. Nandrolone,

s. Norethandrolone,

t. Oxandrolone,

u. Oxymesterone,

v. Oxymetholone,

w. Stanolone,

x. Stanozolol,

y. Testolactone,

z. Testosterone, except as provided in subsection E of

this section, and

aa. Trenbolone;

3. Any substance which contains any quantity of a derivative of

barbituric acid, or any salt of a derivative of barbituric acid;

4. Benzephetamine and its salts;

5. Buprenorphine;

6. Butalbital/acetaminophen/caffeine;

7. Chlorhexadol;

8. Chlorphentermine and its salts;

9. Clortermine;

10. Glutethimide;

11. Ketamine, its salts, isomers, and salts of isomers;

12. Lysergic acid;

13. Lysergic acid amide;

14. Mazindol;

15. Methyprylon;

16. Phendimetrazine;

17. Phenylacetone (P2P);

18. Sulfondiethylmethane;

19. Sulfonethylmethane;

20. Sulfonmethane;

21. Tetrahydrocannibinols;

22. 1-Phenycyclohexylamine; or

23. 1-Piperidinocychexanecarbo nitrile (PCC).

Livestock implants as regulated by the Federal Food and Drug

Administration shall be exempt.

B. Nalorphine.

C. Unless listed in another schedule, any material, compound,

mixture, or preparation containing limited quantities of any of the

following narcotic drugs, or any salts thereof:

1. Not more than one and eight-tenths (1.8) grams of codeine or

any of its salts, per one hundred (100) milliliters or not more than

ninety (90) milligrams per dosage unit, with an equal or greater

quantity of an isoquinoline alkaloid of opium;

2. Not more than one and eight-tenths (1.8) grams of codeine or

any of its salts, per one hundred (100) milliliters or not more than

ninety (90) milligrams per dosage unit, with one or more active,

nonnarcotic ingredients in recognized therapeutic amounts;

3. Not more than one and eight-tenths (1.8) grams of

dihydrocodeine or any of its salts, per one hundred (100)

milliliters or not more than ninety (90) milligrams per dosage unit,

with one or more active, nonnarcotic ingredients in recognized

therapeutic amounts;

4. Not more than three hundred (300) milligrams of

ethylmorphine or any of its salts, per one hundred (100) milliliters

or not more than fifteen (15) milligrams per dosage unit, with one

or more ingredients in recognized therapeutic amounts;

5. Not more than five hundred (500) milligrams of opium per one

hundred (100) milliliters or per one hundred (100) grams, or not

more than twenty-five (25) milligrams per dosage unit, with one or

more active, nonnarcotic ingredients in recognized therapeutic

amounts; or

or not more than fifteen (15) milligrams per dosage unit, with one

or more ingredients in recognized therapeutic amounts;

5. Not more than five hundred (500) milligrams of opium per one

hundred (100) milliliters or per one hundred (100) grams, or not

more than twenty-five (25) milligrams per dosage unit, with one or

more active, nonnarcotic ingredients in recognized therapeutic

amounts; or

6. Not more than fifty (50) milligrams of morphine or any of

its salts, per one hundred (100) milliliters or per one hundred

(100) grams with one or more active, nonnarcotic ingredients in

recognized therapeutic amounts.

D. The Board of Pharmacy may except by rule any compound,

mixture, or preparation containing any stimulant or depressant

substance listed in subsections A and B of this section from the

application of all or any part of the Uniform Controlled Dangerous

Substances Act if the compound, mixture, or preparation contains one

or more active medicinal ingredients not having a stimulant or

depressant effect on the central nervous system, and if the

admixtures are included therein in combinations, quantity,

proportion, or concentration that vitiate the potential for abuse of

the substances which have a stimulant or depressant effect on the

central nervous system.

E. The following hormonal substances or steroids are exempt

from classification as Schedule III controlled dangerous substances:

1. Estratest, containing 1.25 mg esterified estrogens and 2.5

mg methyltestosterone;

2. Estratest HS, containing 0.625 mg esterified estrogens and

1.25 mg methyltestosterone;

3. Premarin with Methyltestosterone, containing 1.25 mg

conjugated estrogens and 10.0 mg methyltestosterone;

4. Premarin with Methyltestosterone, containing 0.625 mg

conjugated estrogens and 5.0 mg methyltestosterone;

5. Testosterone Cypionate - Estrodiol Cypionate injection,

containing 50 mg/ml Testosterone Cypionate; and

6. Testosterone Enanthate - Estradiol Valerate injection,

containing 90 mg/ml Testosterone Enanthate and 4 mg/ml Estradiol

Valerate.